000119906 001__ 119906
000119906 005__ 20240319081016.0
000119906 0247_ $$2doi$$a10.1089/thy.2022.0025
000119906 0248_ $$2sideral$$a130633
000119906 037__ $$aART-2022-130633
000119906 041__ $$aeng
000119906 100__ $$0(orcid)0000-0001-7431-0376$$aAlonso-Ventura, Vanesa$$uUniversidad de Zaragoza
000119906 245__ $$aA cross-sectional study examining the parametric thyroid feedback quantile index and its relationship with metabolic and cardiovascular diseases
000119906 260__ $$c2022
000119906 5060_ $$aAccess copy available to the general public$$fUnrestricted
000119906 5203_ $$aThe usual inverse correlation between thyrotropin (TSH) and thyroid hormone disappears in syndromes of central resistance to thyroid hormone, where both are high. TSH and thyroid hormone are also simultaneously high when there is an elevation of the set point of the thyroid regulation axis. This can be estimated with indices, such as the Parametric Thyroid Feedback Quantile-based Index (PTFQI), which was designed for the general population. The PTFQI is positively associated with diabetes prevalence, but association with other pathologies has not been yet explored. The aim of this project was to explore the potential relationship of the PTFQI with metabolic and cardiovascular disease in a sample of ambulatory adult patients from Spain.
000119906 536__ $$9info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI19-00020
000119906 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000119906 590__ $$a6.6$$b2022
000119906 592__ $$a1.609$$b2022
000119906 591__ $$aENDOCRINOLOGY & METABOLISM$$b24 / 144 = 0.167$$c2022$$dQ1$$eT1
000119906 593__ $$aEndocrinology$$c2022$$dQ1
000119906 593__ $$aMedicine (miscellaneous)$$c2022$$dQ1
000119906 593__ $$aEndocrinology, Diabetes and Metabolism$$c2022$$dQ1
000119906 594__ $$a11.8$$b2022
000119906 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000119906 700__ $$0(orcid)0000-0001-7043-0952$$aCiveira, Fernando$$uUniversidad de Zaragoza
000119906 700__ $$aAlvarado-Rosas, Almendra
000119906 700__ $$0(orcid)0000-0001-9578-6525$$aLou-Bonafonte, Jose Manuel$$uUniversidad de Zaragoza
000119906 700__ $$aCalmarza, Pilar
000119906 700__ $$0(orcid)0000-0003-0604-5042$$aMoreno-Franco, Belen$$uUniversidad de Zaragoza
000119906 700__ $$0(orcid)0000-0002-6361-9228$$aAndres-Otero, María Jesús
000119906 700__ $$0(orcid)0000-0001-7774-8840$$aCalvo-Gracia, Fernando$$uUniversidad de Zaragoza
000119906 700__ $$aDiego-García, Patricia de
000119906 700__ $$0(orcid)0000-0003-3963-0846$$aLaclaustra, Martín$$uUniversidad de Zaragoza
000119906 7102_ $$11012$$2410$$aUniversidad de Zaragoza$$bDpto. Farmac.Fisiol.y Med.L.F.$$cÁrea Fisiología
000119906 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000119906 7102_ $$11011$$2615$$aUniversidad de Zaragoza$$bDpto. Microb.Ped.Radio.Sal.Pú.$$cÁrea Medic.Prevent.Salud Públ.
000119906 773__ $$g32, 12 (2022), [12 pp.]$$pThyroid$$tTHYROID$$x1050-7256
000119906 8564_ $$s4719423$$uhttps://zaguan.unizar.es/record/119906/files/texto_completo.pdf$$yVersión publicada
000119906 8564_ $$s2520650$$uhttps://zaguan.unizar.es/record/119906/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000119906 909CO $$ooai:zaguan.unizar.es:119906$$particulos$$pdriver
000119906 951__ $$a2024-03-18-15:39:08
000119906 980__ $$aARTICLE